94 related articles for article (PubMed ID: 29491081)
1. Surveillance Imaging in HPV-related Oropharyngeal Cancer.
Su W; Miles BA; Posner M; Som P; Kostakoglu L; Gupta V; Bakst RL
Anticancer Res; 2018 Mar; 38(3):1525-1529. PubMed ID: 29491081
[TBL] [Abstract][Full Text] [Related]
2. Utility of a repeat PET/CT scan in HPV-associated Oropharyngeal Cancer following incomplete nodal response from (chemo)radiotherapy.
Liu HY; Milne R; Lock G; Panizza BJ; Bernard A; Foote M; McGrath M; Brown E; Gandhi M; Porceddu SV
Oral Oncol; 2019 Jan; 88():153-159. PubMed ID: 30616786
[TBL] [Abstract][Full Text] [Related]
3. Posttreatment surveillance PET/CT for HPV-associated oropharyngeal cancer.
Corpman DW; Masroor F; Carpenter DM; Nayak S; Gurushanthaiah D; Wang KH
Head Neck; 2019 Feb; 41(2):456-462. PubMed ID: 30549345
[TBL] [Abstract][Full Text] [Related]
4. Significance of Negative Posttreatment 18-FDG PET/CT Imaging in Patients With p16/HPV-Positive Oropharyngeal Cancer.
Ng SP; Johnson JM; Gunn GB; Rosenthal DI; Skinner HD; Phan J; Frank SJ; Morrison W; Sturgis EM; Mott FE; Williams MD; Fuller CD; Garden AS
Int J Radiat Oncol Biol Phys; 2018 Nov; 102(4):1029-1035. PubMed ID: 29960060
[TBL] [Abstract][Full Text] [Related]
5. The prognostic impact of human papillomavirus status following treatment failure in oropharyngeal cancer.
Dave E; Ozbek U; Gupta V; Genden E; Miles B; Teng M; Posner M; Misiukiewicz K; Bakst RL
PLoS One; 2017; 12(7):e0181108. PubMed ID: 28732044
[TBL] [Abstract][Full Text] [Related]
6. Association of follow-up imaging frequency with temporal incidence and patterns of distant failure following (chemo) radiotherapy for HPV related oropharyngeal cancer.
Gaffney J; Ramzan A; Dinizulu T; Maley C; Onamusi O; Motamedi-Ghahfarokhi G; Price G; Metcalf R; Garcez K; Hughes C; Lee L; Thomson D; Price J; Jain Y; McPartlin A
Oral Oncol; 2024 Jan; 148():106645. PubMed ID: 37992488
[TBL] [Abstract][Full Text] [Related]
7. Effect of human papillomavirus on patterns of distant metastatic failure in oropharyngeal squamous cell carcinoma treated with chemoradiotherapy.
Trosman SJ; Koyfman SA; Ward MC; Al-Khudari S; Nwizu T; Greskovich JF; Lamarre ED; Scharpf J; Khan MJ; Lorenz RR; Adelstein DJ; Burkey BB
JAMA Otolaryngol Head Neck Surg; 2015 May; 141(5):457-62. PubMed ID: 25742025
[TBL] [Abstract][Full Text] [Related]
8. Post-treatment 18F-fludeoxyglocuse-positron emission tomography in human papillomavirus-associated oropharyngeal cancer.
Liu ZY; Khoo D; Hartel G; Punyadeera C; Vasani S
Head Neck; 2023 Aug; 45(8):2000-2008. PubMed ID: 37306045
[TBL] [Abstract][Full Text] [Related]
9. Deintensification candidate subgroups in human papillomavirus-related oropharyngeal cancer according to minimal risk of distant metastasis.
O'Sullivan B; Huang SH; Siu LL; Waldron J; Zhao H; Perez-Ordonez B; Weinreb I; Kim J; Ringash J; Bayley A; Dawson LA; Hope A; Cho J; Irish J; Gilbert R; Gullane P; Hui A; Liu FF; Chen E; Xu W
J Clin Oncol; 2013 Feb; 31(5):543-50. PubMed ID: 23295795
[TBL] [Abstract][Full Text] [Related]
10. The value of follow-up FDG-PET/CT in the management and prognosis of patients with HPV-positive oropharyngeal squamous cell carcinoma.
Taghipour M; Marcus C; Califano J; Fakhry C; Subramaniam RM
J Med Imaging Radiat Oncol; 2015 Dec; 59(6):681-6. PubMed ID: 26768092
[TBL] [Abstract][Full Text] [Related]
11. Systematic Review and Meta-Analysis of Post-Treatment PET/CT in HPV-Associated Oropharyngeal Cancer.
Mathews F; Irizarry R; Rosenfeld R; Sundaram K
Ann Otol Rhinol Laryngol; 2022 Jun; 131(6):595-603. PubMed ID: 34353135
[TBL] [Abstract][Full Text] [Related]
12. Natural course of distant metastases following radiotherapy or chemoradiotherapy in HPV-related oropharyngeal cancer.
Huang SH; Perez-Ordonez B; Weinreb I; Hope A; Massey C; Waldron JN; Kim J; Bayley AJ; Cummings B; Cho BC; Ringash J; Dawson LA; Siu LL; Chen E; Irish J; Gullane P; Hui A; Liu FF; Shen X; Xu W; O'Sullivan B
Oral Oncol; 2013 Jan; 49(1):79-85. PubMed ID: 22917550
[TBL] [Abstract][Full Text] [Related]
13. Impact of routine surveillance imaging on detecting recurrence in human papillomavirus associated oropharyngeal cancer.
Canavan JF; Harr BA; Bodmann JW; Reddy CA; Ferrini JR; Ives DI; Chute DJ; Fleming CW; Woody NM; Geiger JL; Joshi NP; Koyfman SA; Adelstein DJ
Oral Oncol; 2020 Apr; 103():104585. PubMed ID: 32044714
[TBL] [Abstract][Full Text] [Related]
14. Bcl2 and human papilloma virus 16 as predictors of outcome following concurrent chemoradiation for advanced oropharyngeal cancer.
Nichols AC; Finkelstein DM; Faquin WC; Westra WH; Mroz EA; Kneuertz P; Begum S; Michaud WA; Busse PM; Clark JR; Rocco JW
Clin Cancer Res; 2010 Apr; 16(7):2138-46. PubMed ID: 20233885
[TBL] [Abstract][Full Text] [Related]
15. Outcomes after salvage for HPV-positive recurrent oropharyngeal cancer treated with primary radiation.
Christopherson KM; Moreno AC; Elgohari B; Gross N; Ferrarotto R; Mohamed ASR; Brandon Gunn G; Goepfert RP; Mott FE; Shah SJ; David Fuller C; Reddy JP; Frank SJ; Morrison WH; Phan J; Rosenthal DI; Garden AS
Oral Oncol; 2021 Feb; 113():105125. PubMed ID: 33360375
[TBL] [Abstract][Full Text] [Related]
16. Serum Antibodies to HPV16 Early Proteins Warrant Investigation as Potential Biomarkers for Risk Stratification and Recurrence of HPV-Associated Oropharyngeal Cancer.
Fakhry C; Qualliotine JR; Zhang Z; Agrawal N; Gaykalova DA; Bishop JA; Subramaniam RM; Koch WM; Chung CH; Eisele DW; Califano J; Viscidi RP
Cancer Prev Res (Phila); 2016 Feb; 9(2):135-41. PubMed ID: 26701665
[TBL] [Abstract][Full Text] [Related]
17. Adjuvant Radiation Therapy Alone for HPV Related Oropharyngeal Cancers with High Risk Features.
Su W; Liu J; Miles BA; Genden EM; Misiukiewicz KJ; Posner M; Gupta V; Bakst RL
PLoS One; 2016; 11(12):e0168061. PubMed ID: 27930732
[TBL] [Abstract][Full Text] [Related]
18. Patient Burden with Current Surveillance Paradigm and Factors Associated with Interest in Altered Surveillance for Early Stage HPV-Related Oropharyngeal Cancer.
Gharzai LA; Burger N; Li P; Jaworski EM; Henderson C; Spector M; Rosko A; Chen MM; Prince ME; Bradford CR; Malloy KM; Stucken CL; Swiecicki P; Worden F; Schipper MJ; Schonewolf CA; Shah J; Jagsi R; Chinn S; Shuman A; Casper K; Mierzwa ML
Oncologist; 2021 Aug; 26(8):676-684. PubMed ID: 33823077
[TBL] [Abstract][Full Text] [Related]
19. Ki67 Expression has Prognostic Significance in Relation to Human Papillomavirus Status in Oropharyngeal Squamous Cell Carcinoma.
Liu J; Zhang M; Rose B; Veillard AS; Jones D; Zhang X; Soon Lee C; Milross C; Hong A
Ann Surg Oncol; 2015; 22(6):1893-900. PubMed ID: 25404475
[TBL] [Abstract][Full Text] [Related]
20. PET/CT imaging and human papilloma virus-positive oropharyngeal squamous cell cancer: evolving clinical imaging paradigm.
Subramaniam RM; Alluri KC; Tahari AK; Aygun N; Quon H
J Nucl Med; 2014 Mar; 55(3):431-8. PubMed ID: 24408893
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
